Preclinical Studies of 64/67Cu-SARTATE for the Treatment of Metastatic Neuroblastoma

Time: 11:00 am
day: Day One

Details:

  • Cu-64/Cu-67 is a theranostic pair with great potential
  • Metastases are a promising target for targeted radionuclide therapy
  • How small can we go? Can we treat minimal residual disease and pre-empt
    metastases?

Speakers: